SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alchemy Pay

Alchemy Pay is trending amid strong community debate, fueled by recent developments including new Money Transmitter Licenses, expanding fiat on-ramps for major stablecoins like Ripple's RLUSD, and the introduction of tokenized stock access. Many see it as a "sleeping giant" poised for a significant structural upgrade with its evolving Alchemy Chain, while others remain skeptical, viewing it as a "pump and dump" despite its growing global payment utility.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending due to recent positive advancements in its HIV pipeline, including favorable trial results for a new regimen and extending market exclusivity for a leading therapy. This comes as the company continues to strategically bolster its oncology and antiviral assets, driving increased analyst interest and discussions around its diversified growth trajectory.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is gaining significant attention due to its prominent partnership with World Liberty Finance and the impending rollout of its Super App, alongside confirmed integration with Stellar and ongoing discussions with Ripple. The community is highly optimistic, emphasizing ZBCN's robust real-world utility in payment and payroll infrastructure, its ISO 20022 and MiCA compliance, and its potential to become a foundational project in the real-world asset (RWA) sector. Many foresee substantial long-term growth, comparing its current positioning to that of early major cryptocurrencies.

Binance Coin is the cryptocurrency of the Binance platform. It is a trading platform exclusively for cryptocurrencies. The name "Binance" is a combination of binary and finance.  Thus, the startup name shows that only cryptocurrencies can be traded against each other. It is not possible to trade crypto currencies against Fiat. The platform achieved an enormous success within a very short time and is focused on worldwide market with Malta headquarters. The cryptocurrency currently has a daily trading volume of 1.5 billion - 2 billion US dollars and is still increasing.  In total, there will only be 200 million BNBs. Binance uses the ERC20 token standard from Ethereum and has distributed it as follow: 50% sold on ICO, 40% to the team and 10% to Angel investors. The coin can be used to pay fees on Binance. These include trading fees, transaction fees, listing fees and others. Binance gives you a huge discount when fees are paid in BNB.   The schedule of BNB fees discount is as follow: In the first year, 50% discount on all fees, second year 25% discount, third year 12.5% discount, fourth year 6.75 % discount, and from the fifth year onwards there is no discount. This structure is used to incentivize users to buy BNB and do trades within Binance.  Binance announced in a buyback plan that it would buy back up to 100 million BNB in Q1 2018. The coins are then burned. This means that they are devaluated to increase the value of the remaining coins. This benefits investors. In the future, the cryptocurrency will remain an asset on the trading platform and will be used as gas.  Other tokens that are issued by exchanges include Bibox Token, OKB, Huobi Token, and more.

Binance

BNB is generating significant buzz due to the recent pardon of Binance founder CZ, which has ignited fresh optimism within the community. Traders are closely monitoring technical indicators, actively discussing potential price rallies and short-term movements. This renewed interest is further amplified by ongoing ecosystem developments, such as new integrations and consistent token burns, reinforcing BNB's utility.

BlackPearl.Chain is pushing decentralization into the future with a third-generation public blockchain. It’s network achieves blazing transaction speeds (Millions TPS) using Sharding and a VRF lightning-fast consensus mechanism built in-house. Finality is achieved in under three seconds with revolutionary P2P, Its speed and security make it the perfect platform for applications like digital asset trading, social media messaging, payment processing, supply chain tracking, and other high-scale use cases.

BlackPearl

The BPLC crypto community is highly optimistic about its long-term potential, with many envisioning it as a future "game changer" in commerce. Enthusiastic investors are comparing it to established digital assets like XRP, eagerly anticipating mainstream exchange adoption and significant market cap expansion.

GitLab, Inc. engages in the intelligent DevSecOps platform for software innovation. The firm enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

Gitlab (GTLB) is actively discussed amid recent stock volatility and downgrades, fueling speculation about its future. The community is sharply divided between those who see it as an undervalued acquisition candidate with strong fundamentals and AI integration, and others who cite persistent losses and competitive pressures in the DevSecOps sector.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs (ALAB) is experiencing significant market volatility and community debate, stemming from recent AI infrastructure news involving a major hyperscaler that sparked sharp price movements. Investors are actively discussing whether the initial market reaction was an overcorrection, with many highlighting ALAB's fundamental strength in high-speed AI connectivity and its long-term potential in the burgeoning semiconductor sector.

Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Inspire Medical Systems Inc

Inspire Medical Systems is currently trending following recent positive regulatory news, as CMS finalized a rule to significantly boost reimbursement rates for its sleep apnea procedures starting in 2026, prompting multiple analyst upgrades. This has ignited bullish community sentiment and a notable stock surge, though ongoing discussions still weigh the potential long-term impact of GLP-1 weight loss drugs on the sleep apnea market.

Hecla Mining Co. engages in the provision of precious and base metals. It operates through the following segments: Greens Creek, Lucky Friday, Keno Hill, Casa Berardi, and Other. The company was founded by Amasa B. Campbell, Patsy Clark, and John Finch on October 14, 1891 and is headquartered in Coeur d'Alene, ID.

Hecla Mining Co.

Hecla Mining Co

Hecla Mining is trending amid a significant surge in silver prices, with community discussions buzzing about predictions of triple-digit silver ($100-$150+) driven by industrial demand and a looming supply deficit. Investors are keenly anticipating that this metal rally will soon translate into a dramatic outperformance for silver miners, positioning HL as a key US and Canada-based producer. Despite some short-term lag, strong conviction exists that upcoming earnings and critical supply dynamics will trigger a substantial re-rating for the stock.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian ($TEAM) is trending as the broader software sector experiences significant pressure, driven by fears of AI disruption to core offerings like Jira and Confluence. While many in the community perceive the downturn as an overreaction and a buying opportunity given the company's solid fundamentals and AI integration efforts, concerns about continued weakness and insider selling persist among others.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arrowhead Pharmaceuticals, Inc. $ARWR Shares Acquired by Nordea Investment Management AB

Nordea Investment Management AB boosted its position in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Free Report) by 74.5% during the third quarter, according to its most recent Form 13F...

SG Americas Securities LLC Boosts Stake in Arrowhead Pharmaceuticals, Inc. $ARWR

SG Americas Securities LLC grew its position in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Free Report) by 418.1% during the 3rd quarter, according to the company in its most recent...

Arrowhead Pharmaceuticals Touts Rudemplo Launch, Obesity RNAi Data and $920M Cash at JPM Conference

Arrowhead Pharmaceuticals (NASDAQ:ARWR) used its presentation at the JPMorgan Healthcare Conference to highlight a newly launched RNA interference (RNAi) therapy, a broad clinical-stage pipeline, and...

Is Arrowhead Pharmaceuticals Stock a Buy or Sell After the CEO Sold Shares Worth $5.4 Million?

Key PointsCEO Christopher Anzalone sold 85,000 shares in the open market on Dec. 17, 2025, for a transaction value of ~$5,443,462...

Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the Chinese National Medical Products Administration (NMPA) has approved REDEMPLO (plozasiran) for the reduction of triglyceride...

Arrowhead Pharmaceuticals Announces Proposed Offerings of Convertible Senior Notes and Common Stock

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its intention to offer, subject to market and other conditions, $500 million aggregate principal amount of convertible senior notes due...

Arrowhead Pharmaceuticals Shares Early RNAi Obesity Data, Highlights Visceral Fat Drops and Combo Potential

Arrowhead Pharmaceuticals (NASDAQ:ARWR) shared initial interim clinical results from two RNA interference (RNAi) obesity candidates, ARO-INHBE and ARO-ALK7, during a virtual key opinion leader (KOL...

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Reaches New 52-Week High - Time to Buy?

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Hits New 1-Year High - Here's What Happened...

Arrowhead Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:ARWR)

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR - Get Free Report) saw some unusual options trading on Tuesday. Traders purchased 5,093 call options on the company. This represents an increase of...

Arrowhead Obesity Drugs Show Significant Fat Loss In Early Human Trials

Arrowhead Pharmaceuticals reported early trial data showing notable reductions in body, liver, and visceral fat from two experimental obesity drugs, with more results expected in 2026.read more...

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Current Price	$64.02
Prev Close	$66.25
Open	$66.45
Dividend Yield	0.00%
50-Day Moving Average	$58.33
Beta	1.57
Avg. Volume	2.67M
PE Ratio	-950.00

52-Week High	$76.76
52-Week Low	$9.57
Market Capitalization	$8.67B
EPS (Annual)	-$0.0122
Price to Book	18.59
Revenue Per Employee	$1.17M
Enterprise Value/EBITDA	N/A

ARWR
Arrowhead Pharmaceuticals Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ARWR News

ARWRArrowhead Pharmaceuticals Inc.